Fig. 4From: Impact of clinical parameters and systemic inflammatory status on epidermal growth factor receptor-mutant non-small cell lung cancer patients readministration with epidermal growth factor receptor tyrosine kinase inhibitorsInfluence of trends of lymphocyte-to-monocyte ratio (LMR) on overall survival (OS) of patients who were readministered with tyrosine kinase inhibitors OS between patients with high and low trend of LMRBack to article page
